Description：Rabbit polyclonal antibody to BRCA1 (Phospho-S1423)Immunogen：KLH-conjugated synthetic phosphopeptide corresponding to residues surrounding S1423 of human BRCA1 protein. The exact sequence is proprietary.Purification：The antibody was purified by immunogen affinity chromatography.Clonality：PolyclonalForm：Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.Dilution：WB (1/500 - 1/1000), IH (1/100 - 1/200), IF/IC (1/100 - 1/500)Gene Symbol：BRCA1Alternative Names：RNF53; Breast cancer type 1 susceptibility protein; RING finger protein 53 Entrez Gene (Human)： 672; Entrez Gene (Rat)： 497672; SwissProt (Human)： P38398; SwissProt (Rat)： O54952; Storage/Stability：Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.

• 
  Western blot analysis of BRCA1 (Phospho-S1423) expression in Hela UV-treated (A), K562 UV-treated (B) whole cell lysates. (Predicted band size: 207 kD; Observed band size: 220 kD)
• 
  Immunohistochemical analysis of BRCA1 (Phospho-S1423) staining in human lung cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
• 
  Immunofluorescent analysis of BRCA1 (Phospho-S1423) staining in HeLa cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 °C in a hidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark.